Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Clark, C. M.
space
  arrow  Karlawish, J. H.T.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

UPDATE

Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies

right arrow Christopher M. Clark, MD, and Jason H.T. Karlawish, MD

4 March 2003 | Volume 138 Issue 5 | Pages 400-410

Alzheimer disease is a complex neurodegenerative dementing illness. It has become a major public health problem because of its increasing prevalence, long duration, high cost of care, and lack of disease-modifying therapy. Over the past few years, however, remarkable advances have taken place in understanding both the genetic and molecular biology associated with the intracellular processing of amyloid and tau and the changes leading to the pathologic formation of extracellular amyloid plaques and the intraneuronal aggregation of hyperphosphorylated tau into neurofibrillary tangles. The identification of disease-causing autosomal dominant mutations as well as gene polymorphisms that alter the risk for pathology indicate that Alzheimer disease is a genetically complex disorder. This progress in our understanding of the molecular pathology has set the stage for clinically meaningful advances in diagnosis and treatment. Emerging diagnostic methods that are based on biochemical and imaging biomarkers of disease-specific pathology hold the potential for accurately diagnosing Alzheimer disease at the earliest stage of the illness—the time when disease-modifying treatment will be most effective. Currently available cholinesterase inhibition therapy targets the cognitive symptoms. However, the goal of new therapies under development is halting the pathologic cascade and potentially reversing the course of the disease. If these new therapies are successful, they will represent a remarkable medical advance for patients and the families who care for them.

Author and Article Information
space

From the University of Pennsylvania, Philadelphia, Pennsylvania.

Grant Support: By National Institute on Aging (NIA) grants AG10124 and AG09215. Dr. Karlawish was funded by a Paul Beeson Fellowship and by NIA grants K01-AG00931 and P01-AG10124.

Corresponding Author: Christopher M. Clark, MD, Memory Disorders Clinic, Penn-Ralston Center, the University of Pennsylvania, 3615 Chestnut Street, Philadelphia, PA 19104.

Potential Financial Conflicts of Interest: Dr. Clark has been a paid participant in advisory board meetings for Janssen Pharmaceutica, Parke-Davis, Eisai, and Elan (formerly Athena Neurosciences). He has received honoraria from Parke-Davis, Eisai, and Pfizer for giving educational presentations on the diagnosis and treatment of Alzeheimer disease. Dr. Clark has also participated in research studies sponsored by Elan, Eisai, and Parke-Davis. Dr. Karlawish has received an educational grant from Ortho-McNeil.

Current Author Addresses: Drs. Clark and Karlawish: Memory Disorders Clinic, Penn-Ralston Center, University of Pennsylvania, 3615 Chestnut Street, Philadelphia, PA 19104.


Related articles in Annals:

Reviews
Diagnostic Evaluation of Elderly Patients with Mild Memory Problems
Jason H.T. Karlawish AND Christopher M. Clark
Annals 2003 138: 411-419. [ABSTRACT][Full Text]  

Letters
Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies
Thomas E. Finucane
Annals 2004 140: 71. [Full Text]  

Letters
Diagnostic Evaluation of Elderly Patients with Mild Memory Problems
Ronald Hirsch
Annals 2004 140: 71. [Full Text]  

Letters
Diagnostic Evaluation of Elderly Patients with Mild Memory Problems
Monica S. Horton AND Jason E. Schillerstrom
Annals 2004 140: 71-72. [Full Text]  

Letters
Diagnostic Evaluation of Elderly Patients with Mild Memory Problems
Jason Karlawish AND Christopher M. Clark
Annals 2004 140: 72. [Full Text]  



This article has been cited by other articles:


Home page
BrainHome page
H.-W. Klafki, M. Staufenbiel, J. Kornhuber, and J. Wiltfang
Therapeutic approaches to Alzheimer's disease
Brain, November 1, 2006; 129(11): 2840 - 2855.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Endocr. Rev., December 1, 2005; 26(7): 916 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Mor, M. Izak, and I. R. Cohen
Identification of Aldolase as a Target Antigen in Alzheimer's Disease
J. Immunol., September 1, 2005; 175(5): 3439 - 3445.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
S. A. Linnebur and J. M. Ruscin
Cholinesterase inhibitor use in geriatric outpatients with dementia
Am. J. Health Syst. Pharm., May 1, 2005; 62(9): 923 - 926.
[Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
A. B. Reiss
Cholesterol and apolipoprotein E in Alzheimer's disease
American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 91 - 96.
[Abstract] [PDF]


Home page
JAMAHome page
K. M. Langa, N. L. Foster, and E. B. Larson
Mixed Dementia: Emerging Concepts and Therapeutic Implications
JAMA, December 15, 2004; 292(23): 2901 - 2908.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
T. E. Finucane
Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies
Ann Intern Med, January 6, 2004; 140(1): 71 - 71.
[Full Text] [PDF]


Home page
RadiologyHome page
R. M. Friedenberg
Dementia: One of the Greatest Fears of Aging
Radiology, December 1, 2003; 229(3): 632 - 635.
[Full Text] [PDF]


Home page
ScienceHome page
J. L. Kennedy, L. A. Farrer, N. C. Andreasen, R. Mayeux, and P. St George-Hyslop
The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra?
Science, October 31, 2003; 302(5646): 822 - 826.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
E. W. Gregg and A. Brown
Cognitive and Physical Disabilities and Aging-Related Complications of Diabetes
Clin. Diabetes, July 1, 2003; 21(3): 113 - 118.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2003 by the American College of Physicians.